The current and future burden of heart failure in Portugal

Abstract

Aims Heart failure (HF) is a clinical syndrome with significant social and economic burden. We aimed to estimate the burden of HF in mainland Portugal over a 22‐year time horizon, between 2014 and 2036. Methods and results Heart failure burden was measured in disability‐adjusted life years (DALYs), resulting from the sum of years of life lost (YLL) due to premature death and years lost due to disability (YLD). YLL were estimated based on the Portuguese mortality rates reported by the European Detailed Mortality Database. For YLD, disease duration and the overall incidence were estimated using an epidemiological model developed by the World Health Organization (DISMOD II). Disability weights were retrieved from published literature. The impact of ageing was estimated with a shift‐share analysis using official demographic projections. In 2014, 4688 deaths were attributed to HF, corresponding to 4.7% of the total deaths in mainland Portugal. DALYs totalled 21 162, 53.9% due to premature death (YLL: 11 398) and 46.1% due to disability (YLD: 9765). Considering only population ageing over a 22‐year horizon, the deaths and burden of HF are expected to increase by 73.0% and 27.9%, respectively, reaching 8112 deaths and 27 059 DALYs lost due to HF in 2036. DALY's growth is mainly driven by the increase of YLL, whose contribution to overall burden will increase to 62.0%. Conclusions Heart failure is an emerging and growing health problem where significant health gains may be obtained. The projected significant increase of HF burden highlights the need to set HF as a priority for healthcare system.

The Self‐Care of Heart Failure Index version 7.2: Further psychometric testing

“…Despite scientific advances, heart failure (HF) remains a major health problem, with estimates of 26 million individuals affected worldwide (Savarese & Lund, 2017). Recent projections in Europe suggest that in the next two decades, HF prevalence will increase 2–3‐fold as a result of the aging of the population and improved survival (Danielsen et al, 2017; Gouveia et al, 2019). HF causes significant symptom burden, high mortality and morbidity, and extensive use of health care services (von Lueder & Agewall, 2018).…”

10 year trends in hospitalization rates due to heart failure and related in‐hospital mortality in Poland (2010–2019)

“…Information on current realities in HF care and outcomes would support the physicians and health care policymakers in their efforts to improve the systems of HF management, also through the optimal allocation of funds for the prevention, diagnosis, and treatment of HF, and to identify clinical problems that could be targets of innovative diagnostic and therapeutic approaches. [19][20][21] Moreover, the better understanding of contemporary HF epidemiology would also help in developing better management and educational programmes addressed to patients with HF and their caregivers. 22 Therefore, we performed study in order to determine the trends in hospitalization rates due to HF and related in-hospital mortality in the recent decade, with an additional focus on age-related and gender-related differences in investigated epidemiological patterns.…”

Tendências da Insuficiência Cardíaca na Paraíba: Diagnóstico mais Precoce ou Melhor Tratamento? Eis uma das Questões

“…DOI: https://doi.org/10.36660/abc.20190898 A Insuficiência Cardíaca (IC) é uma síndrome clínica com alta prevalência, morbidade e mortalidade no mundo todo [1][2][3][4][5][6][7] . É também uma das principais causas de internações hospitalares, com custos diretos e indiretos elevados.…”

“…É também uma das principais causas de internações hospitalares, com custos diretos e indiretos elevados. [1][2][3][4][5][6][7] É esperado que a prevalência de IC aumente devido ao aumento dos fatores de risco cardiovascular na população em geral e aumento da expectativa de vida. Pacientes idosos são mais propensos ao desenvolvimento de IC, bem como de internações por IC.…”

“…Por esse motivo, espera-se um aumento no ônus econômico da IC nas próximas décadas. [1][2][3][4][5][6][7] Dados publicados anteriormente mostraram, entretanto, algumas diferenças epidemiológicas de acordo com a região do mundo, quando países em desenvolvimento e desenvolvidos foram comparados. Dados recentemente publicados do Heart Failure Long-term Registry da Sociedade Europeia de Cardiologia, um registro que incluiu um amplo espectro de países com antecedentes socioeconômicos muito diferentes, do sul, oeste, norte e leste da Europa, além do Oriente Médio e Norte da África, mostrou diferenças significativas entre as regiões em relação às características basais, características clínicas e também tratamento e desfechos em pacientes com IC aguda e crônica.…”